Human secretin is a gastrointestinal peptide hormone that regulates secretions in the stomach, pancreas, and liver. Synthetic human secretin displays equivalent biological activity and properties as naturally occurring secretin. Acetate salt of synthetic secretin was marketed under the name ChiRhoStim. ChiRhoStim is indicated for the stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction, for the gastrin secretion to aid in the diagnosis of gastrinoma. ChiRhoStim is also used for the pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic, retrograde cholangiopancreatography (ERCP). When secretin binds to secretin receptors on pancreatic duct cells it opens cystic fibrosis transmembrane conductance regulator (CFTR) channels, leading to secretion of bicarbonate-rich-pancreatic fluid.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P47872 Gene ID: 6344.0 Gene Symbol: SCTR Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21542831 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | ChiRhoStim Approved UseChiRhoStim® is a secretin class hormone indicated for stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of exocrine pancreas dysfunction; gastrin secretion to aid in the diagnosis of gastrinoma; pancreatic secretions to facilitate the identification of the ampulla of Vater and the accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP). Launch Date2004 |
Sample Use Guides
Stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of exocrine pancreas dysfunction: 0.2 mcg/kg by intravenous injection over 1 minute
Stimulation of gastrin secretion to aid in diagnosis of gastrinoma:0.4 mcg/kg by intravenous injection over 1 minute
Stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography ERCP): 0.2 mcg/kg by intravenous injection over 1 minute
Route of Administration:
Intravenous
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 16:52:21 GMT 2023
by
admin
on
Sat Dec 16 16:52:21 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
A0426J905J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
219906
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
||
|
FDA ORPHAN DRUG |
120798
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
||
|
FDA ORPHAN DRUG |
120598
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
||
|
FDA ORPHAN DRUG |
130199
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
||
|
FDA ORPHAN DRUG |
120698
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
||
|
NCI_THESAURUS |
C1937
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID701026608
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
A0426J905J
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
606396
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB34843
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
m9828
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | Merck Index | ||
|
108153-74-8
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
2548
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201488
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
C47713
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
9510
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
A0426J905J
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
DB09532
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
100000128122
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY | |||
|
SUB34934
Created by
admin on Sat Dec 16 16:52:22 GMT 2023 , Edited by admin on Sat Dec 16 16:52:22 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
INGREDIENT -> STARTING MATERIAL |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:SEQUENCE(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|